MoneyWorks4Me

Gujarat Terce Labs. - Quaterly Results

08 Aug 2026 Evaluate
Net sales declined -17.06%  to  Rs. 90.02 million from Rs. 108.54 millions.The Net Loss for the quarter ended June 2026 is Rs. -1.77 millions as compared to Net Loss of Rs. -0.44 millions of corresponding quarter ended June 2025Operating profit Margin for the quarter ended June 2026 slipped to -0.10% as compared to 0.73% of corresponding quarter ended June 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 90.02 108.54 -17.06 90.02 108.54 -17.06 474.73 501.95 -5.42
Other Income 4.82 0.95 407.37 4.82 0.95 407.37 3.40 3.08 10.39
PBIDT -0.10 0.73 -113.70 -0.10 0.73 -113.70 40.89 41.90 -2.41
Interest 0.32 0.49 -34.69 0.32 0.49 -34.69 1.80 4.15 -56.63
PBDT -0.42 0.24 -275.00 -0.42 0.24 -275.00 34.55 37.75 -8.48
Depreciation 1.06 0.96 10.42 1.06 0.96 10.42 4.23 3.85 9.87
PBT -1.48 -0.72 105.56 -1.48 -0.72 105.56 30.32 33.90 -10.56
TAX 0.29 -0.28 -203.57 0.29 -0.28 -203.57 8.31 43.69 -80.98
Deferred Tax 0.29 -0.28 -203.57 0.29 -0.28 -203.57 -2.57 7.88 -132.61
PAT -1.77 -0.44 302.27 -1.77 -0.44 302.27 22.01 -9.79 -324.82
Equity 77.91 74.20 5.00 77.91 74.20 5.00 77.91 74.20 5.00
PBIDTM(%) -0.11 0.67 -116.52 -0.11 0.67 -116.52 8.61 8.35 3.19
Peers
Company Name CMP
Sun Pharma. Inds. 1852.40
Dr. Reddys Labs. 1201.00
Cipla 1407.70
Lupin 2085.50
Zydus Lifesciences 1195.25
View more..